title: Hypersensitivity to nabumetone: cross reactivity with naproxen.
authors.forename: Patricia Rojas
authors.initials: PR
authors.lastname: Perez-Ezquerra
authors.forename: Leticia
authors.initials: L
authors.lastname: Sanchez-Morillas
authors.forename: Jose Julio
authors.initials: JJ
authors.lastname: Laguna Martinez
authors.forename: Rosario
authors.initials: R
authors.lastname: Gonzalez Mendiola
authors.forename: Carmen
authors.initials: C
authors.lastname: Gomez-Traseira
authors.forename: Irene
authors.initials: I
authors.lastname: Carrasco Garcia
authors.forename: Mariana
authors.initials: M
authors.lastname: Herranz Mañas
authors.forename: Almudena
authors.initials: A
authors.lastname: Rubio Matos
mesh_terms: D000328:Adult; D000799:Angioedema / Q000209:etiology; D002074:Butanones / Q000009:adverse effects* / Q000276:immunology* / Q000627:therapeutic use; D003429:Cross Reactions; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects* / Q000276:immunology*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use; D004342:Drug Hypersensitivity / Q000276:immunology*; D005260:Female; D006801:Humans; D008875:Middle Aged; D000077430:Nabumetone; D009288:Naproxen / Q000009:adverse effects / Q000276:immunology* / Q000627:therapeutic use; D014581:Urticaria / Q000209:etiology
chemical_list: D002074:Butanones; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D009288:Naproxen; D000077430:Nabumetone